REQUEST A DEMO
Total
USD $0.00
Search more companies

Bio-Relax Centrum Medyczne Sp. z o.o. (Poland)

Main Activities: Offices of Physicians
Full name: Bio-Relax Centrum Medyczne Sp. z o.o. Profile Updated: June 22, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Bio-Relax Centrum Medyczne Sp. z o.o. is an enterprise in Poland, with the main office in Pulawy. The enterprise currently operates in the Offices of Physicians sector. It was established on May 20, 2017. From the latest financial highlights, Bio-Relax Centrum Medyczne Sp. z o.o. reported a net sales revenue increase of 24.66% in 2023. A growth of 14.93% was recorded in its total assets. The net profit margin of Bio-Relax Centrum Medyczne Sp. z o.o. decreased by 0.34% in 2023.

Headquarters
Ul. Zielona 28A
Pulawy; Lubelskie; Postal Code: 24-100

Contact Details: Purchase the Bio-Relax Centrum Medyczne Sp. z o.o. report to view the information.

Website: http://www.bio-relax.pulawy.pl

Basic Information
Outstanding Shares:
Purchase the Bio-Relax Centrum Medyczne Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Bio-Relax Centrum Medyczne Sp. z o.o. report to view the information.
Incorporation Date:
May 20, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
51.67%
Purchase this report to view the information.
48.33%
Company Performance
Financial values in the chart are available after Bio-Relax Centrum Medyczne Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
24.66%
Total operating revenue
24.24%
Operating profit (EBIT)
20.81%
EBITDA
21.63%
Net Profit (Loss) for the Period
21.17%
Total assets
14.93%
Total equity
25.85%
Operating Profit Margin (ROS)
-0.46%
Net Profit Margin
-0.34%
Return on Equity (ROE)
-2.37%
Debt to Equity Ratio
-5.12%
Quick Ratio
0.97%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?